Evergreen Therapeutics
Focus: Evergreen Therapeutics is an AI-focused pharmaceutical company headquartered in Hong Kong with a portfolio centered on generic cholesterol-management drugs and specialized therapeutics. Currently operating with minimal commercial scale, the company derives 100% of revenue from Pitavastatin Calcium.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Evergreen Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Evergreen Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Evergreen Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$393K Part DDeclining
Post-LOE
Sole revenue driver (100% of company revenue) but off-patent generic with minimal market share and only $393K in Part D spending.
Help build intelligence for Evergreen Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.